Researchers have mapped the regulatory elements that control the FOXP3 gene, which is implicated in maintaining balance in ...

AAV-SLB101 is a rationally designed capsid developed for enhanced skeletal muscle, cardiac tropism, and reduced biodistribution to the liver.

With the global technical textiles market heading toward $200B by 2030 , KBLB’s timing could enable early adoption and prototype work for 2026 procurement cycles, especially in high-performance and ...

Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for ...

DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market ...

Non-exclusive license providing Solid’s proprietary, next-generation capsid, AAV-SLB101, to Andelyn Biosciences, a ...

The up to $1.4M collaboration will enable manufacturing “universal” islets containing a drug-inducible safety feature designed to make curative therapies accessible without the need for chronic ...

The food biotechnology market is projected to grow substantially over the next decade, rising from an estimated USD 32.5 ...

Growing concerns over foodborne illness and shifting consumer expectations for safe, transparent, and minimally processed food are accelerating the adoption of advanced pathogen detection technologies ...

New simulations reveal interstellar objects don't arrive uniformly, with concentrations from the solar apex and galactic ...